Search Page

1

Cite

Share

Ischaemic conditioning: are we there yet?

Bulluck H, Hausenloy DJ. Bulluck H, et al. Heart. 2015 Jul;101(13):1067-77. doi: 10.1136/heartjnl-2014-306531. Epub 2015 Apr 17. Heart. 2015. PMID: 25887783 Free article. Review. No abstract available.

Cite

Share

2

Cite

Share

Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury.

Ong SB, Katwadi K, Kwek XY, Ismail NI, Chinda K, Ong SG, Hausenloy DJ. Ong SB, et al. Expert Opin Ther Targets. 2018 Mar;22(3):247-261. doi: 10.1080/14728222.2018.1439015. Expert Opin Ther Targets. 2018. PMID: 29417868 Review.

Cite

Share

3

Cite

Share

The therapeutic potential of ischemic conditioning: an update.

Hausenloy DJ, Yellon DM. Hausenloy DJ, et al. Nat Rev Cardiol. 2011 Jun 21;8(11):619-29. doi: 10.1038/nrcardio.2011.85. Nat Rev Cardiol. 2011. PMID: 21691310 Review.

Cite

Share

4

Cite

Share

Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).

Hausenloy DJ. Hausenloy DJ. Curr Pharm Des. 2013;19(25):4544-63. doi: 10.2174/1381612811319250004. Curr Pharm Des. 2013. PMID: 23270554 Review.

Cite

Share

5

Cite

Share

New horizons for newborn brain protection: enhancing endogenous neuroprotection.

Hassell KJ, Ezzati M, Alonso-Alconada D, Hausenloy DJ, Robertson NJ. Hassell KJ, et al. Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F541-52. doi: 10.1136/archdischild-2014-306284. Epub 2015 Jun 10. Arch Dis Child Fetal Neonatal Ed. 2015. PMID: 26063194 Free PMC article. Review.

Cite

Share

6

Cite

Share

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Bøtker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femminò S, García-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhäuser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schlüter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G. Bøtker HE, et al. Basic Res Cardiol. 2018 Aug 17;113(5):39. doi: 10.1007/s00395-018-0696-8. Basic Res Cardiol. 2018. PMID: 30120595 Free PMC article. Review. No abstract available.

Cite

Share

7

Cite

Share

Contrast-induced nephropathy following angiography and cardiac interventions.

Rear R, Bell RM, Hausenloy DJ. Rear R, et al. Heart. 2016 Apr;102(8):638-48. doi: 10.1136/heartjnl-2014-306962. Epub 2016 Feb 8. Heart. 2016. PMID: 26857214 Free PMC article. No abstract available.

Cite

Share

8

Cite

Share

Platelet inhibition to target reperfusion injury trial: Rationale and study design.

Bulluck H, Chan MHH, Bryant JA, Chai P, Chawla A, Chua TS, Chung YC, Fei G, Ho HH, Ho AFW, Hoe AJ, Imran SS, Lee CH, Lim SH, Liew BW, Yun PLZ, Hock MOE, Paradies V, Roe MT, Teo L, Wong AS, Wong E, Wong PE, Watson T, Chan MY, Tan JW, Hausenloy DJ. Bulluck H, et al. Clin Cardiol. 2019 Jan;42(1):5-12. doi: 10.1002/clc.23110. Epub 2018 Dec 17. Clin Cardiol. 2019. PMID: 30421441 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury.

Cabrera-Fuentes HA, Ruiz-Meana M, Simsekyilmaz S, Kostin S, Inserte J, Saffarzadeh M, Galuska SP, Vijayan V, Barba I, Barreto G, Fischer S, Lochnit G, Ilinskaya ON, Baumgart-Vogt E, Böning A, Lecour S, Hausenloy DJ, Liehn EA, Garcia-Dorado D, Schlüter KD, Preissner KT. Cabrera-Fuentes HA, et al. Thromb Haemost. 2014 Dec;112(6):1110-9. doi: 10.1160/TH14-08-0703. Epub 2014 Oct 30. Thromb Haemost. 2014. PMID: 25354936

Cite

Share